Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 308, pseudogene (RN7SL308P)

Target: RN7SL308P
Molecular classification: Pseudogene, Non-coding RNA (genomic locus, not a functional transcript)

Overview

RN7SL308P, or RNA, 7SL, cytoplasmic 308, pseudogene, is a human genomic locus classified as a pseudogene derived from the 7SL RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in the co-translational targeting of protein synthesis[1][3][6][7]. Pseudogenes like RN7SL308P are typically truncated and nonfunctional copies, produced through reverse transcription of RNA into DNA and inserted into the genome[1][3]. Most 7SL pseudogenes, including RN7SL308P, are not expressed as functional RNA in cells[1][3]. While some pseudogenes can regulate gene expression or affect disease, no specific functions, disease associations, or therapeutic interventions are attributed to RN7SL308P as of current knowledge[2][4][5].

Other names: RN7SL308PRNA, 7SL, cytoplasmic 308, pseudogene

Biological functions

None directly established for RN7SL308P (as a specific locus)Serve as decoys or sponges for microRNAs, affecting parent gene expression (general pseudogene function)Regulate chromatin or genomic architecture (general pseudogene function)Participate in transcript-splicing or recombination (general pseudogene function)Potential RNA-based regulatory functions if transcribed (general pseudogene function)For most 7SL pseudogenes, there is little or no detectable expression

Disease associations

None established or reported for RN7SL308P itselfPseudogenes in general can have regulatory roles linked to cancer and other diseases, but no direct evidence for this locus

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 308, pseudogene (RN7SL308P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 308, pseudogene (RN7SL308P).

Explore the full profile